Treatment Outcomes of Concurrent Chemoradiotherapy for Locally Advanced NSCLC: A Single-Center Experience

Locally advanced non-small cell lung cancer (NSCLC) poses a significant therapeutic challenge, often managed with concurrent chemoradiotherapy (CRT). Evaluating treatment outcomes in real-world settings is crucial for optimizing patient care. Objective: This study aimed to assess the treatment outcomes of concurrent CRT in patients with locally advanced NSCLC treated Method: A prospective analysis was conducted on 90 patients at the Department of Radiation Oncology, Rajshahi Medical College Hospital, Rajshahi, from July 2020 to June 2022, with locally advanced NSCLC who received concurrent CRT during the period. Data on patient demographics, tumor characteristics, treatment regimens, response rates, and toxicities were collected from medical records. Treatment response was evaluated using RECIST criteria, and toxicities were graded based on CTCAE v5.0. Results: Among the 90 patients included, the median age was 60 years (range: 45-75 years), with 65